Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background The rarity of systemic sclerosis (SSc) has hampered the development of therapies for this intractable autoimmune disease. Induced pluripotent stem cell (iPSC) can be differentiated into the key disease-affected cells in vitro. The generation of patient-derived iPSCs has opened up possibilities for rare disease modeling. Since these cells...
Alternative Titles
Full title
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d8f924033e754e57bb1a6eaaf5e8c11b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8f924033e754e57bb1a6eaaf5e8c11b
Other Identifiers
ISSN
1757-6512
E-ISSN
1757-6512
DOI
10.1186/s13287-022-02987-w
